GI
EWTX icon

GAMMA Investing’s Edgewise Therapeutics EWTX Stock Holding History

GAMMA Investing’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.6K Sell
2,107
-182
-8% -$6.27K ﹤0.01% 1924
2026
Q1 		$72.1K Buy
2,289
+935
+69% +$27K ﹤0.01% 1905
2025
Q4 		$33.6K Buy
1,354
+196
+17% +$3.93K ﹤0.01% 2318
2025
Q3 		$18.8K Sell
1,158
-8
-0.7% -$113 ﹤0.01% 2543
2025
Q2 		$15.3K Sell
1,166
-241
-17% -$3.48K ﹤0.01% 2597
2025
Q1 		$31K Buy
1,407
+86
+7% +$2.26K ﹤0.01% 2138
2024
Q4 		$35.3K Buy
1,321
+33
+3% +$1.05K ﹤0.01% 1932
2024
Q3 		$34.4K Buy
1,288
+101
+9% +$2.01K ﹤0.01% 1754
2024
Q2 		$21.4K Sell
1,187
-19
-2% -$331 ﹤0.01% 1812
2024
Q1 		$22K Buy
1,206
+100
+9% +$1.59K ﹤0.01% 1584
2023
Q4 		$19.7K Buy
+1,106
New +$7.76K 0.01% 1518

Other funds holding EWTX

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EC
Eleva Capital Paris, France $343M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM